#

Pharmaceutical Companies

: 104
Nike will release its quarterly results after the markets close on June 30 / Photo: Unsplash/Craig Lovelidge
News·
Morning in New York: Nike's Earnings Report and Negotiations Over the Strait of Hormuz Take Center Stage
Abivax Biotech Soars 36%: New Tests Allay Investors Fears / Photo: Abivax.com
News·
Abivax shares soared 36%. The company dispelled concerns about a cancer-causing drug
Shares of vaccine manufacturer Moderna hit their highest level since September 2024 / Photo: Panaceum Media / Shutterstock.com
News·
Moderna shares hit a two-year high after a 13% surge. It's all about a new treatment
Pfizers experimental lung cancer drug failed to extend patients survival / Photo: Flowersandtraveling / Shutterstock.com
News·
Pfizer's lung cancer drug trial has failed. What will happen to the stock?
AbbVie Acquires Psoriasis Drug Developer for $10.9 Billion / Photo: AbbVie
News·
AbbVie will acquire a psoriasis drug developer for $11 billion. Its stock rose 47%.
According to sources cited by the Financial Times, the pharmaceutical company AbbVie is preparing to acquire Apogee for $11 billion / Photo: abbvie.scene7.com
News·
AbbVie is preparing to acquire a dermatitis drug developer for $11 billion — FT
The head of Perplexity clarified the companys plans to go public in 2028 / Photo: miss.cabul / Shutterstock.com
Review·
Highlights for the morning: Iran threat, OpenAI and Perplexity's IPO plans, GSK's big deal
Eli Lillys new obesity drug led to weight loss by more than a quarter / Photo: Jonathan Weiss / Shutterstock.com
News·
'Eli Lilly pulls ahead': investors praise new obesity drug
Abivax shares collapsed nearly 30% after new data on its drug was released / Photo: abivax.com
News·
Shares of biotech Abivax plummet 30% after reports of cancer in trial participants
Eli Lilly will buy three vaccine developers. Photo: ChrisStock82/Shutterstock
News·
Eli Lilly will invest nearly $4 billion to buy three vaccine developers. Why would she do that?
Before considering a purchase of this once-popular and now apparently undervalued stock, keep in mind that the company faces many hurdles in taking on competitors like Novo Nordisk and Eli Lilly, a new Motley Fool article argues / Photo: Facebook/Nasdaq
Small Caps·
Motley Fool: May be too late for dark horse role for Viking in GLP-1 wars
An outbreak of a dangerous hantavirus infection occurred on the cruise liner MV Hondius. Passengers were evacuated and the liner arrived at the port of Rotterdam on May 18. Photo: Chris McGrath/Getty Images
Review·
WHO reports hantavirus and a dangerous Ebola outbreak. Will this set off a new vaccine race?
Load more